Warner John O
Emeritus Professor of Paediatrics, National Heart and Lung Institute, Imperial College, London SW3 6LY, UK.
Honorary Professor of Paediatrics, University of Cape Town, Cape Town, WC 7701, South Africa.
J Clin Med. 2020 May 14;9(5):1483. doi: 10.3390/jcm9051483.
While allergy, asthma and rhinitis do not inevitably co-exist, there are strong associations. Not all those with asthma are allergic, rhinitis may exist without asthma, and allergy commonly exists in the absence of asthma and/or rhinitis. This is likely due to the separate gene/environment interactions which influence susceptibility to allergic sensitization and allergic airway diseases. Allergic sensitization, particularly to foods, and eczema commonly manifest early in infancy, and not infrequently are followed by the development of allergic rhinitis and ultimately asthma. This has become known as the "allergic march". However, many infants with eczema never develop asthma or rhinitis, and both the latter conditions can evolve without prior eczema or food allergy. Understanding the mechanisms underlying the ontogeny of allergic sensitization and allergic disease will facilitate rational approaches to the prevention and management of asthma and allergic rhinitis. Furthermore, a range of new, so-called biological, therapeutic approaches, targeting specific allergy-promoting and pro-inflammatory molecules, are now in clinical trials or have been recently approved for use by regulatory authorities and could have a major impact on disease prevention and control in the future. Understanding basic mechanisms will be essential to the employment of such medications. This review will explain the concept of the united airway (rhinitis/asthma) and associations with allergy. It will incorporate understanding of the role of genes and environment in relation to the distinct but interacting origins of allergy and rhinitis/asthma. Understanding the patho-physiological differences and varying therapeutic requirements in patients with asthma, with or without rhinitis, and with or without associated allergy, will aid the planning of a personalized evidence-based management strategy.
虽然过敏、哮喘和鼻炎并非必然同时存在,但它们之间存在很强的关联。并非所有哮喘患者都有过敏反应,鼻炎可能在没有哮喘的情况下存在,而过敏也通常在没有哮喘和/或鼻炎的情况下存在。这可能是由于影响过敏致敏和过敏性气道疾病易感性的基因/环境相互作用不同。过敏致敏,尤其是对食物的过敏致敏,以及湿疹通常在婴儿早期出现,而且常常随后发展为过敏性鼻炎,最终发展为哮喘。这被称为“过敏进程”。然而,许多患有湿疹的婴儿从未发展为哮喘或鼻炎,而后两种疾病也可能在没有先前湿疹或食物过敏的情况下演变而来。了解过敏致敏和过敏性疾病发生发展的潜在机制将有助于制定合理的哮喘和过敏性鼻炎预防及管理方法。此外,一系列针对特定促进过敏和促炎分子的新型所谓生物治疗方法目前正在进行临床试验,或最近已获监管机构批准使用,可能会对未来疾病的预防和控制产生重大影响。了解基本机制对于使用此类药物至关重要。本综述将解释联合气道(鼻炎/哮喘)的概念及其与过敏的关联。它将纳入对基因和环境在过敏与鼻炎/哮喘不同但相互作用的起源方面所起作用的理解。了解哮喘患者(无论有无鼻炎,有无相关过敏)的病理生理差异和不同的治疗需求,将有助于规划个性化的循证管理策略。